ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
Wang R, Liu X, Li X, Qian M, Yang X, Jiang Q, Wang Y, Liu H, Chen J, Wang X, et al. Mol Carcinog. 2024 Jun; 63(6):1079-1091. Epub 2024 Mar 1.